Viewing Study NCT05518734


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-31 @ 4:31 PM
Study NCT ID: NCT05518734
Status: COMPLETED
Last Update Posted: 2023-03-30
First Post: 2022-08-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Dose Escalation Study of VX-708 in Healthy Participants
Sponsor: Vertex Pharmaceuticals Incorporated
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module